Literature DB >> 25527711

FDG PET-CT in follicular lymphoma: a case-based evidence review.

Stephen D Smith1, Mary Redman2, Kieron Dunleavy3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25527711      PMCID： PMC4326769          DOI： 10.1182/blood-2014-11-537522

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  46 in total

1.  Utility of FDG-PET scanning in lymphoma by WHO classification.

Authors:  Rebecca Elstrom; Liang Guan; Gary Baker; Khozaim Nakhoda; Jo-Anne Vergilio; Hongming Zhuang; Stephanie Pitsilos; Adam Bagg; Lisa Downs; Amit Mehrotra; Scott Kim; Abass Alavi; Stephen J Schuster
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

2.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

3.  Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Authors:  Lalitha K Shankar; John M Hoffman; Steve Bacharach; Michael M Graham; Joel Karp; Adriaan A Lammertsma; Steven Larson; David A Mankoff; Barry A Siegel; Annick Van den Abbeele; Jeffrey Yap; Daniel Sullivan
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

4.  Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas.

Authors:  Maroun Karam; Leon Novak; Jomol Cyriac; Ameera Ali; Tipu Nazeer; Francis Nugent
Journal:  Cancer       Date:  2006-07-01       Impact factor: 6.860

5.  Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.

Authors:  Hervé Ghesquières; Françoise Berger; Pascale Felman; Evelyne Callet-Bauchu; Paul-André Bryon; Alexandra Traverse-Glehen; Catherine Thieblemont; Lucile Baseggio; Anne-Sophie Michallet; Bertrand Coiffier; Gilles Salles
Journal:  J Clin Oncol       Date:  2006-10-16       Impact factor: 44.544

6.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

7.  Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

Authors:  Heiko Schöder; Ariela Noy; Mithat Gönen; Lijun Weng; David Green; Yusuf E Erdi; Steven M Larson; Henry W D Yeung
Journal:  J Clin Oncol       Date:  2005-04-18       Impact factor: 44.544

8.  Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL).

Authors:  G Jerusalem; Y Beguin; F Najjar; R Hustinx; M F Fassotte; P Rigo; G Fillet
Journal:  Ann Oncol       Date:  2001-06       Impact factor: 32.976

9.  18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading.

Authors:  S Wöhrer; U Jaeger; K Kletter; A Becherer; A Hauswirth; K Turetschek; M Raderer; M Hoffmann
Journal:  Ann Oncol       Date:  2006-02-23       Impact factor: 32.976

10.  Follicular lymphoma international prognostic index.

Authors:  Philippe Solal-Céligny; Pascal Roy; Philippe Colombat; Josephine White; Jim O Armitage; Reyes Arranz-Saez; Wing Y Au; Monica Bellei; Pauline Brice; Dolores Caballero; Bertrand Coiffier; Eulogio Conde-Garcia; Chantal Doyen; Massimo Federico; Richard I Fisher; Javier F Garcia-Conde; Cesare Guglielmi; Anton Hagenbeek; Corinne Haïoun; Michael LeBlanc; Andrew T Lister; Armando Lopez-Guillermo; Peter McLaughlin; Noël Milpied; Pierre Morel; Nicolas Mounier; Stephen J Proctor; Ama Rohatiner; Paul Smith; Pierre Soubeyran; Hervé Tilly; Umberto Vitolo; Pier-Luigi Zinzani; Emanuele Zucca; Emili Montserrat
Journal:  Blood       Date:  2004-05-04       Impact factor: 22.113
View more
  11 in total

1.  PET/CT-based bone-marrow assessment shows potential in replacing routine bone-marrow biopsy in part of patients newly diagnosed with extranodal natural killer/T-cell lymphoma.

Authors:  Yiqin Wang; Li Xie; Rong Tian; Yaotiao Deng; Wenyan Zhang; Liqun Zou; Hong Zhang; Jie Liu; Sha Zhao; Wenshuang Ding; Weiping Liu; Ming Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-04       Impact factor: 4.553

Review 2.  Current trends in diagnosis and management of follicular lymphoma.

Authors:  Gopila Gupta; Vikas Garg; Saumyaranjan Mallick; Ajay Gogia
Journal:  Am J Blood Res       Date:  2022-08-15

Review 3.  PET-CT in Staging, Response Evaluation, and Surveillance of Lymphoma.

Authors:  Gita Thanarajasingam; Nabila Bennani-Baiti; Carrie A Thompson
Journal:  Curr Treat Options Oncol       Date:  2016-05

Review 4.  Whole body magnetic resonance in indolent lymphomas under watchful waiting: The time is now.

Authors:  Massimo Galia; Domenico Albano; Corrado Tarella; Caterina Patti; Luca Maria Sconfienza; Antonino Mulè; Pierpaolo Alongi; Massimo Midiri; Roberto Lagalla
Journal:  Eur Radiol       Date:  2017-10-10       Impact factor: 5.315

5.  Evaluating Novel PET-CT Functional Parameters TLG and TMTV in Differentiating Low-grade Versus Grade 3A Follicular Lymphoma.

Authors:  Ajay Major; Andrew Hammes; Matthew Q Schmidt; Rustain Morgan; Diana Abbott; Manali Kamdar
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-09-28

6.  Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy.

Authors:  Murali Kesavan; Jan Boucek; William MacDonald; Andrew McQuillan; J Harvey Turner
Journal:  Diagnostics (Basel)       Date:  2017-05-12

7.  Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma.

Authors:  Paolo Strati; Mohamed Amin Ahmed; Nathan H Fowler; Loretta J Nastoupil; Felipe Samaniego; Luis E Fayad; Fredrick B Hagemeister; Jorge E Romaguera; Alma Rodriguez; Michael Wang; Jason R Westin; Chan Cheah; Mansoor Noorani; Lei Feng; Richard E Davis; Sattva S Neelapu
Journal:  Haematologica       Date:  2019-10-10       Impact factor: 9.941

8.  Application of Quantitative Indexes of FDG PET to Treatment Response Evaluation in Indolent Lymphoma.

Authors:  Hyun Joo Kim; Reeree Lee; Hongyoon Choi; Jin Chul Paeng; Gi Jeong Cheon; Dong Soo Lee; June-Key Chung; Keon Wook Kang
Journal:  Nucl Med Mol Imaging       Date:  2018-08-30

9.  18F-Fluorodeoxyglucose positron emission tomography computed tomography detection threshold in follicular lymphoma: A case report.

Authors:  Sarah Péricart; Guillaume Martin-Blondel; Camille Franchet; Anne Hitzel; Pierre Brousset
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

Review 10.  Radiotherapy for Non-Hodgkin's lymphoma: still standard practice and not an outdated treatment option.

Authors:  Michel Zimmermann; Christoph Oehler; Ulrich Mey; Pirus Ghadjar; Daniel Rudolf Zwahlen
Journal:  Radiat Oncol       Date:  2016-08-30       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.